EUVIMEDEUVIMED entdecken
Crossref

Molecular Mechanism-Driven Discovery of Novel Small Molecule Inhibitors against Drug-Resistant SARS-CoV-2 M pro Variants

Jingyi Yang, Beibei Fu, Rongpei Gou, Xiaoyuan Lin, Haibo Wu, Weiwei Xue iD

Journal of Chemical Information and Modeling · 28.10.2024 · 64 (20) · 7998-8009

DOI: 10.1021/acs.jcim.4c01206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Chemical Information and Modeling, online erschienen am 10.10.2024. Verfasst von Jingyi Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmaceutical Sciences, Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Chongqing University, Chongqing 401331, C…. Hauptthemen laut MEDLINE: SARS-CoV-2, Antiviral Agents, Molecular Dynamics Simulation, Drug Resistance, Viral. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2Antiviral AgentsMolecular Dynamics SimulationDrug Resistance, ViralHumansMolecular Docking SimulationMutationDrug DiscoveryCoronavirus 3C ProteasesCOVID-19 Drug TreatmentSmall Molecule LibrariesDrug Design

Substanzen

Antiviral AgentsCoronavirus 3C ProteasesSmall Molecule Libraries

Autor:innen und Institutionen

  • School of Pharmaceutical Sciences, Chongqing Key Laboratory of Natural Product Synthesis and Drug Research, Chongqing University, Chongqing 401331, China.
  • School of Life Sciences, Chongqing University, Chongqing 401331, China.
  • Department of Clinical Microbiology and Immunology, College of Pharmacy and Medical Laboratory, Army Medical University (Third Military Medical University), Chongqing 400038, China.

ORCID-Profile: Weiwei Xue

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Yang, J., Fu, B., Gou, R., Lin, X., Wu, H., & Xue, W. (2024). Molecular Mechanism-Driven Discovery of Novel Small Molecule Inhibitors against Drug-Resistant SARS-CoV-2 M pro Variants. Journal of Chemical Information and Modeling, 64(20), 7998-8009. https://doi.org/10.1021/acs.jcim.4c01206

Vancouver

Yang J, Fu B, Gou R, Lin X, Wu H, Xue W. Molecular Mechanism-Driven Discovery of Novel Small Molecule Inhibitors against Drug-Resistant SARS-CoV-2 M pro Variants. Journal of Chemical Information and Modeling. 2024;64(20):7998-8009. doi:10.1021/acs.jcim.4c01206

BibTeX
@article{Yang2024,
  author = {Yang, Jingyi and Fu, Beibei and Gou, Rongpei and Lin, Xiaoyuan and Wu, Haibo and Xue, Weiwei},
  title = {Molecular Mechanism-Driven Discovery of Novel Small Molecule Inhibitors against Drug-Resistant SARS-CoV-2 M pro Variants},
  journal = {Journal of Chemical Information and Modeling},
  year = {2024},
  volume = {64},
  number = {20},
  pages = {7998--8009},
  doi = {10.1021/acs.jcim.4c01206}
}
Kostenlos starten →